ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1698

Development of Machine Learning Models (Artificial Neural Networks) for Prediction of Vision Threatening Behçet’s Disease

Nevin Hammam1, Eiman Abd El-Latif 2, Iman I El-Gazzar 3, Nermeen Samy 4, Rasha A Abdel Noor 5, Emad El-Shebeiny 6, Amany R El-Najjar 7, Nahla N Eesa 8, Mohamed N Salem 9, Soha E Ibrahim 10, Dina F El-Essawi 11, Ahmed M Elsaman 12, Hanan M Fathi 13, Rehab A Sallam 14, Rawhya R El-Shereef 15, Mervat I Abd-Elazeem 16, Emtethal A Said 17, Noha M Khalil 18, Dina Shahin 19, Hanan M El-Saadany 20, Marwa S ElKhalifa 21, Samah I Nasef 22, Ahmed M Abdalla 23, Nermeen Noshy 4, Rasha M Fawzy 24, Ehab Saad 25, Abdel-Hafeez Moshrif 26, Amira T El-Shanawany 27, Yousra H Abdel-Fattah 28, Hossam M Khalil 29 and Tamer A Gheita 30, 1University of Alberta, Edmonton, AB, Canada, 2Ophthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt, Alexandria, Egypt, 3Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt, Cairo, Egypt, 4Internal Medicine Department, Rheumatology Unit, Faculty of Medicine, Ain-Shams University, Cairo, Egypt, Cairo, Egypt, 5Internal Medicine Department, Rheumatology Unit, Tanta University, Gharbia, Egypt, Gharbia, Egypt, 6Internal Medicine Department, Rheumatology Unit, Menoufia University, Menoufia, Egypt, Menoufia, Egypt, 7Rheumatology Department, Faculty of Medicine, Zagazig University, Sharkia, Egypt, Sharkia, Egypt, 8Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt., Cairo, Egypt, 9Internal Medicine Department, Rheumatology Unit, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt, Beni-Suef, Egypt, 10Rheumatology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt, Cairo, Egypt, 11Internal Medicine Department, Rheumatology Unit (NCRRT), Atomic Energy Authority (AEA), Cairo, Egypt, Cairo, Egypt, 12Rheumatology Department, Faculty of Medicine, Sohag University, Sohag, Egypt., Sohag, Egypt, 13Rheumatology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt, Fayoum, Egypt, 14Rheumatology Department, Faculty of Medicine, Mansoura University, Dakahlia, Egypt, Dakahlia, Egypt, 15Rheumatology Department, Faculty of Medicine, Minia University, Minia, Egypt., Minia, Egypt, 16Rheumatology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt, Beni-Suef, Egypt, 17Rheumatology Department, Faculty of Medicine, Benha University, Kalubia, Egypt, Benha, Egypt, 18Internal Medicine Department, Rheumatology Unit, Faculty of Medicine, Cairo University, Cairo, Egypt, Cairo, Egypt, 19Internal Medicine Department, Rheumatology Unit, Faculty of Medicine, Mansoura University, Dakahlia, Egypt, Dakahlia, Egypt, 20Rheumatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt, Tanta, Egypt, 21Internal Medicine Department, Rheumatology Unit, Faculty of Medicine, Alexandria University, Alexandria, Egypt, Alexandria, Egypt, 22Rheumatology Department, Faculty of Medicine, Suez-Canal University, Ismailia, Egypt, Ismailia, Egypt, 23Rheumatology Department, Faculty of Medicine, Aswan University, Aswan, Egypt, Aswan, Egypt, 24Rheumatology Department, Faculty of Medicine, Benha University, Kalubia, Egypt, Kalubia, Egypt, 25Rheumatology Department, Faculty of Medicine, South Valley University, Qena, Egypt, Qena, Egypt, 26Rheumatology Department, Faculty of Medicine, Al-Azhar University, Assuit, Egypt, Assiut, Egypt, 27Rheumatology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt, Menoufia, Egypt, 28Rheumatology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt, Alexandria, Egypt, 29Ophthalmology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt., Beni-Suef, Egypt, 30Rheumatology Department, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt., Cairo, Egypt

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Behcet's syndrome, C Reactive Protein, ocular involvement and big data

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III: Behçet’s Disease & Other Vasculitides

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Ocular involvement in Behçet’s Disease (BD) is associated with chronic damage and high morbidity; however, limited evidence is available on risk factors to recognize the subset of BD patients at jeopardy to develop vision-threatening disease (VTD). There is a clear need for identification of those patients early in order to reduce morbidity. Machine learning (ML), including Artificial Neural Networks (ANNs), have been used to forecast complex disease outcomes in the medical setting including rheumatology. Using the Egyptian College of Rheumatology (ECR) cohort data available, we aimed to develop a data-driven ECR-BD accurate model to predict the risk of VTD using ML techniques, with a combination of demographic, clinical, and biochemical information.

Methods: Out of an ECR-BD, a large multicentric cohort, 1094 patients fulfilling the 2014 International Study Group diagnostic criteria for BD were included. VTD was determined by the presence of retinal disease and/or optic nerve affection and/or occurrence of blindness. Twenty-seven variables including patient demographics, clinical manifestations, comorbidities, medications and laboratory data for each patient were used as predictors (inputs) for building-up and testing the ANNs. Prior to the training of the ANNs, the dataset was randomly split into training (80%), and testing (20%) data. The testing set was used to evaluate the final performance of the networks. Inputs were normalized before being entered in networks. Several networks with different properties were trained, and the performance of each network was evaluated. In order to evaluate and select the most accurate network, we used a confusion matrix (sensitivity, specificity, and accuracy), the receiver operating characteristic (ROC) curve and the area under the ROC curve(AUC) of each network and compared them to the logistic regression (LR) model results. R studio v. 3.5.0 software was used to design the neural networks and LR.

Results: A total of 1094 BD patients [71.5% were men, mean ± SD age; 36.1 ± 10 years; and median disease duration 72 months] had complete ocular manifestations data. The mean BD current activity form was 4.7±3.7. About 75% of the ECR-BD cohort had at least one form of ocular involvements, 49.8% of them had VTD. By applying ANNs, we obtained a model (2 hidden layer and 4 neurons) characterized by a sensitivity of 90%, a specificity of 64%, an accuracy of 77%, and AUC value of 0.86, able to predict VTD. These measures for the LR were 73%, 65%, 76.8%, and AUC value of 0.74 respectively. The ANNs results suggest that C-reactive protein is the most important positive predictor of VTD, followed by disease duration, oral ulcers, and presence of diabetes mellitus.

Conclusion: These findings suggest that the artificial neural network could be an accurate technique for prediction of vision-threatening BD. Therefore, building accurate ML models allowed to identify patients at risk to develop VTD in a large BD cohort. The application of this model on longitudinal data in future work is required.

References:

Gheita TA, ECR-BD study group, et al. Behçet’s Disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature. Clin Rheumatolo. 2019 May 22.

The ROC graph of the Logistic regression analysis for predicting vision-threatening outcomes in BD patients.

The ROC graph of the selected artificial neural networks for predicting vision-threatening outcomes in BD patients.


Disclosure: N. Hammam, None; E. Abd El-Latif, None; I. I El-Gazzar, None; N. Samy, None; R. A Abdel Noor, None; E. El-Shebeiny, None; A. R El-Najjar, None; N. N Eesa, None; M. N Salem, None; S. E Ibrahim, None; D. F El-Essawi, None; A. M Elsaman, None; H. M Fathi, None; R. A Sallam, None; R. R El-Shereef, None; M. I Abd-Elazeem, None; E. A Said, None; N. M Khalil, None; D. Shahin, None; H. M El-Saadany, None; M. S ElKhalifa, None; S. I Nasef, None; A. M Abdalla, None; N. Noshy, None; R. M Fawzy, None; E. Saad, None; A. Moshrif, None; A. T El-Shanawany, None; Y. H Abdel-Fattah, None; H. M Khalil, None; T. Gheita, None.

To cite this abstract in AMA style:

Hammam N, Abd El-Latif E, I El-Gazzar I, Samy N, A Abdel Noor R, El-Shebeiny E, R El-Najjar A, N Eesa N, N Salem M, E Ibrahim S, F El-Essawi D, M Elsaman A, M Fathi H, A Sallam R, R El-Shereef R, I Abd-Elazeem M, A Said E, M Khalil N, Shahin D, M El-Saadany H, S ElKhalifa M, I Nasef S, M Abdalla A, Noshy N, M Fawzy R, Saad E, Moshrif A, T El-Shanawany A, H Abdel-Fattah Y, M Khalil H, Gheita T. Development of Machine Learning Models (Artificial Neural Networks) for Prediction of Vision Threatening Behçet’s Disease [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/development-of-machine-learning-models-artificial-neural-networks-for-prediction-of-vision-threatening-behcets-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-machine-learning-models-artificial-neural-networks-for-prediction-of-vision-threatening-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology